Results 111 to 120 of about 313,560 (297)

Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA‐TMA)

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Inappropriate complement activation is a key driver of hematopoietic cell transplant‐associated thrombotic microangiopathy (TA‐TMA). Treatment with narsoplimab, an inhibitor of MASP‐2, the effector enzyme of the lectin pathway, resulted in a response rate of 61% in a Phase 2 clinical trial in adults with TA‐TMA.
Michelle L. Schoettler   +6 more
wiley   +1 more source

CHEMOCOMMUNICATION AT HUMANS AND THE POSSIBILITY OF NON-INVASIVE ASSESSMENT OF THEIR FUNCTIONAL AND PSYCHOSOCIAL STATE ON THE BASIS OF VOLATILE METABOLISM PRODUCTS

open access: yesВестник Кемеровского государственного университета, 2013
Subjective estimation of intensity and attractivity of the odor of sweat collected in axillary pits on filter paper is investigatedat 155 young males and 128 young females who were both donors and recipients of odor samples.
N. A. Litvinova   +7 more
doaj  

Hereditary C7 deficiency. Diagnosis and HLA studies in a French-Canadian family. [PDF]

open access: bronze, 1977
J.-M. Del′ge   +4 more
openalex   +1 more source

Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Selecting the optimal donor is crucial for optimizing results of allogeneic hematopoietic cell transplantation (allo‐HCT). We analyzed outcomes based on donor type in 2809 myelofibrosis (MF) patients undergoing first allo‐HCT between 2015 and 2021 at EBMT centers.
Juan Carlos Hernández‐Boluda   +24 more
wiley   +1 more source

IMMUNOGENICITY OF HLA ANTIGENS PURIFIED FROM SERUM1

open access: bronze, 1977
Soldano Ferrone   +4 more
openalex   +1 more source

HLA-B27 frequency in Greek patients with acute anterior uveitis. [PDF]

open access: bronze, 1977
J. Zervas   +4 more
openalex   +1 more source

Comorbidities in Mild WAS/XLT Require Lifelong Follow‐Up and Consideration of Definitive Treatment

open access: yesAmerican Journal of Hematology, EarlyView.
Our study followed the clinical and biological course of 261 WAS/XLT patients, including 170 with a mild form of the disease. The occurrence of late complications even in mild patients confirms the importance of offering lifelong follow‐up and considering definitive treatment (HSCT/gene therapy) for all patients.
Coralie Mallebranche   +16 more
wiley   +1 more source

HLA-B5 Associated with Duodenal Ulcer

open access: bronze, 1977
Jerome I. Rotter   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy